These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31345843)

  • 21. Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008-11).
    Österblad M; Kirveskari J; Hakanen AJ; Tissari P; Vaara M; Jalava J
    J Antimicrob Chemother; 2012 Dec; 67(12):2860-4. PubMed ID: 22855858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789).
    Del Franco M; Paone L; Novati R; Giacomazzi CG; Bagattini M; Galotto C; Montanera PG; Triassi M; Zarrilli R
    BMC Microbiol; 2015 Nov; 15(1):260. PubMed ID: 26552763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
    Zhang Y; Wang Q; Yin Y; Chen H; Jin L; Gu B; Xie L; Yang C; Ma X; Li H; Li W; Zhang X; Liao K; Man S; Wang S; Wen H; Li B; Guo Z; Tian J; Pei F; Liu L; Zhang L; Zou C; Hu T; Cai J; Yang H; Huang J; Jia X; Huang W; Cao B; Wang H
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
    Stock I
    Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.
    Satlin MJ; Chen L; Patel G; Gomez-Simmonds A; Weston G; Kim AC; Seo SK; Rosenthal ME; Sperber SJ; Jenkins SG; Hamula CL; Uhlemann AC; Levi MH; Fries BC; Tang YW; Juretschko S; Rojtman AD; Hong T; Mathema B; Jacobs MR; Walsh TJ; Bonomo RA; Kreiswirth BN
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
    Huang SS; Lee MH; Leu HS
    J Microbiol Immunol Infect; 2006 Dec; 39(6):496-502. PubMed ID: 17164953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous Infection with
    Khan A; Shropshire WC; Hanson B; Dinh AQ; Wanger A; Ostrosky-Zeichner L; Arias CA; Miller WR
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31658962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Infections by OXA-48-Producing Enterobacteriaceae.
    Stewart A; Harris P; Henderson A; Paterson D
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand.
    Rimrang B; Chanawong A; Lulitanond A; Wilailuckana C; Charoensri N; Sribenjalux P; Phumsrikaew W; Wonglakorn L; Kerdsin A; Chetchotisakd P
    J Antimicrob Chemother; 2012 Nov; 67(11):2626-30. PubMed ID: 22796889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
    Goodman KE; Simner PJ; Tamma PD; Milstone AM
    Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid detection of IMP, NDM, VIM, KPC and OXA-48-like carbapenemases from Enterobacteriales and Gram-negative non-fermenter bacteria by real-time PCR and melt-curve analysis.
    Mentasti M; Prime K; Sands K; Khan S; Wootton M
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2029-2036. PubMed ID: 31385145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a new rapid test for carbapenemase detection in carbapenem resistant Enterobacteriaceae.
    Martino MD; Koga PC; Pasternak J; Doi AM; Ciola CS; da Silva CB; Massaia IF; da Silva IG; de Araújo MR
    J Microbiol Methods; 2015 Aug; 115():20-1. PubMed ID: 25953145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of MASTDISCS combi Carba plus for the identification of metallo-β-lactamases, KPC and OXA-48 carbapenemase genes in Enterobacteriaceae clinical isolates.
    Hu W; Li M; Lu W; Guo S; Li J
    Lett Appl Microbiol; 2020 Jan; 70(1):42-47. PubMed ID: 31642085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center.
    Aitken SL; Tarrand JJ; Deshpande LM; Tverdek FP; Jones AL; Shelburne SA; Prince RA; Bhatti MM; Rolston KVI; Jones RN; Castanheira M; Chemaly RF
    Clin Infect Dis; 2016 Oct; 63(7):954-958. PubMed ID: 27313265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings.
    Bou G; Vila J; Seral C; Castillo FJ
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():24-32. PubMed ID: 25542049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First description of bla(NDM-1), bla(OXA-48), bla(OXA-181) producing Enterobacteriaceae strains in Romania.
    Székely E; Damjanova I; Jánvári L; Vas KE; Molnár S; Bilca DV; Lőrinczi LK; Tóth A
    Int J Med Microbiol; 2013 Dec; 303(8):697-700. PubMed ID: 24183483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.
    Huang TD; Berhin C; Bogaerts P; Glupczynski Y;
    J Antimicrob Chemother; 2013 Aug; 68(8):1832-7. PubMed ID: 23557926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftazidime/avibactam versus standard-of-care agents against carbapenem-resistant Enterobacteriaceae harbouring blaKPC in a one-compartment pharmacokinetic/pharmacodynamic model.
    Barber KE; Pogue JM; Warnock HD; Bonomo RA; Kaye KS
    J Antimicrob Chemother; 2018 Sep; 73(9):2405-2410. PubMed ID: 29939267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility testing in predicting the presence of carbapenemase genes in Enterobacteriaceae in South Africa.
    Singh-Moodley A; Perovic O
    BMC Infect Dis; 2016 Oct; 16(1):536. PubMed ID: 27716102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations.
    Dupont H; Gaillot O; Goetgheluck AS; Plassart C; Emond JP; Lecuru M; Gaillard N; Derdouri S; Lemaire B; Girard de Courtilles M; Cattoir V; Mammeri H
    Antimicrob Agents Chemother; 2016 Jan; 60(1):215-21. PubMed ID: 26482307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.